Myomo Inc (MYO) - Long-Term Liabilities to Capital

Corporate emblem and logo of Myomo, Inc. (MYO)

Risks for Myomo, Inc. (MYO) are linked to a dependence on insurance reimbursements for MyoPro; however, the share of long-term loans to equity on the general GURU.Markets platform chart, where 2.99 represents the latest metric reading, confirms stability. Myomo, Inc. (MYO)'s status as a leader in myoelectrics and the trust of physicians mitigate volatility, while product uniqueness and government program approvals ensure high margins and increased efficiency.

Long-Term Debt to Capital: Myomo, Inc (MYO) for 07/04/2022 - 10/31/2026
Core merchandise of myomo.com

This indicator determines the share of long-term liabilities within the equity structure, measuring financial leverage and default risk in the event of declining revenues. By analyzing the long-term debt-to-equity ratio, an investor assesses the business's ability to service loans with maturities exceeding one year. For Myomo, Inc. (MYO), this metric is critical, as demand for exoskeletons remains stable and independent of market cycles. Insurance coverage of patient expenses minimizes the risk of insolvency. Low revenue volatility renders the debt load predictable and sustainable.

Competing companies

Boston Scientific Corp - Long-Term Liabilities to Equity|Long-Term Debt to Capital EW|RMD - Long-Term Liabilities to Capital|Long-Term Debt to Capital PODD (Insulet Corporation)|ZBH - Long-Term Debt to Equity Ratio|CooperCompanies - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Invisalign ALGN|GMED: Long-Term Debt to Capital|TransMedics Group, Inc. (TMDX) - Long-Term Debt to Capital|Long-Term Debt to Equity Alphatec Holdings, Inc.|Long-Term Debt to Equity AORT|Long-Term Debt to Capital ENOV|Ratio of Long-Term Indebtedness to Capital Integra LifeSciences Corp|Motiva - Long-Term Debt to Equity Ratio|BBNX (iLet Bionic Pancreas) - Long-Term Liabilities to Equity|IRADIMED CORPORATION - Long-Term Debt to Capital|Long-Term Liabilities to Capital embecta.com|TNDM: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio AXGN|Long-Term Debt to Equity Ratio SIBN|OFIX: Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Bioventus Inc. (BVS)|Long-Term Debt to Equity Ratio orthopediatrics.com KIDS|Long-Term Debt to Capital TMCI (Treace Medical Concepts, Inc.)|Blade Air Mobility (SRTA) - Long-Term Liabilities to Capital|Carlsmed Corp - Long-Term Debt to Capital|RXST (RxSight Ophthalmic) - Long-Term Debt to Capital Ratio|CLPT: Long-Term Debt to Capital|STXS - Ratio of Long-Term Indebtedness to Capital|STIM (Neuronetics) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Sight Sciences Inc. (SGHT)|Long-Term Debt to Capital OBIO|Long-Term Debt to Capital anikatherapeutics.com (ANIK)|Long-Term Debt to Equity InspireMD, Inc. NSPR|Jin Medical International Ltd. - Long-Term Debt to Equity|VANI: Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient XTNT (Xtant Medical Holdings)|NMTC: Long-Term Debt to Capital|Long-Term Liabilities to Capital Modular Medical, Inc. (MODD)|Long-Term Debt to Equity Envoy Medical, Inc.|VVOS - Long-Term Indebtedness to Equity|Long-Term Debt to Equity Ratio NVNO (enVVeno Medical Corp.)|Long-Term Debt to Capital sintx.com (SINT)|Long-Term Debt to Capital TNON (Tenon Medical, Inc)|Ratio of Long-Term Indebtedness to Capital Lifeward Ltd. (LFWD)|AMIX - Long-Term Debt to Equity|Long-Term Liabilities to Equity IVF|Bone Biologics Corp (BBLG) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Axonics Inc.|BIOL (Biolase, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital Dynatronics Corp. DYNT|Long-Term Debt to Equity Paragon 28, Inc. (FNA)|invobioscience.com - Long-Term Debt to Capital Ratio